NtAP1L protein resistant to tobacco brown spot disease and its encoding gene and application

By discovering the NtAP1L protein and its encoding genes related to the resistance to tobacco red star disease, especially the InDel 25 locus, the problem of insufficient anti-red star disease ability of existing tobacco varieties was solved, and the selection of new anti-red star disease genes and proteins was achieved. The cultivation and application significantly improves the resistance of tobacco and reduces the use of chemical pesticides.

CN113943357BInactive Publication Date: 2024-11-26GUIZHOU TOBACCO SCI RES INST
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202111120072.6
Authority / Receiving Office
CN · China
Patent Type
Patents(China)
Current Assignee / Owner
Filing Date
2021-09-24
Publication Date
2024-11-26
Estimated Expiration
Not applicable · inactive patent

AI Technical Summary

Technical Problem

The existing tobacco varieties are insufficient to resist tobacco red star disease, and there are already large differences in the resistance of anti-bacco red star disease varieties, and there is a lack of effective chemical pesticides to prevent and treat the disease, resulting in serious losses in tobacco leaf production.

Method used

The NtAP1L protein and its encoding genes that resist tobacco red star disease were developed. Through genome mixed pool sequencing and differential site analysis, it was found that the InDel 25 locus was closely related to the resistance to tobacco red star disease, which promoted the new anti-red star disease genes and proteins. Breeding and application.

Benefits of technology

It provides new ways and more choices, providing new possibilities for the breeding and application of tobacco resistant to red star disease varieties, significantly improving tobacco's resistance to red star disease and reducing the use of chemical pesticides.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN113943357B_ABST
    Figure CN113943357B_ABST
Patent Text Reader

Abstract

The present invention relates to the technical field of plant resistance, and discloses a NtAP1L protein resistant to tobacco brown spot disease, including the NtAP1L protein and its encoding gene; and also discloses applications. The present invention develops new genes and related proteins with tobacco brown spot disease resistance, providing new ways and more options for the breeding and application of tobacco varieties resistant to brown spot disease.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present invention relates to the technical field of plant resistance, and in particular to a tobacco brown spot disease-resistant NtAP1L protein and a coding gene and application thereof. Background Art

[0002] Tobacco is an important economic crop and an annual herbaceous plant of the Solanaceae family. Tobacco Brownspot is a common fungal disease of tobacco, especially in the middle and late stages of tobacco leaf growth, and has become an obstacle to tobacco leaf growth. The pathogen is Alternaria alternnata (Fries) Keissler, which can infect potatoes, tomatoes, eggplants, peppers, nightshade, Datura, etc. of the Solanaceae family. Brownspot bacteria overwinter on the remains of diseased plants or weeds. The conidia produced on the lesions are spread by wind and rain to form re-infection, and the leaves are susceptible to the disease in the middle and late stages of leaf growth. Since tobacco brownspot has the characteristics of a short incubation period and a fast epidemic speed, it can cause a pandemic in a short time under suitable environmental conditions, causing huge losses to tobacco leaf production. The commonly used control drugs are chemical drugs such as carbendazim, polyoxin, and methyl thiophanate. Due to years of use, the bacteria have developed resistance and have little effect.

[0003] Breeding tobacco varieties resistant to brown spot disease can reduce or even avoid the use of chemical pesticides for brown spot disease. Although there are currently varieties resistant to brown spot disease, there are no completely immune varieties. In addition, there are obvious differences in disease resistance among tobacco varieties resistant to brown spot disease, and there are relatively few varieties resistant to brown spot disease that can be used in production. Therefore, breeding work for resistance to brown spot disease should be strengthened. Summary of the invention

[0004] Based on the above problems, the present invention provides a NtAP1L protein resistant to tobacco brown spot disease and its encoding gene and application. The present invention develops new genes and related proteins with tobacco brown spot disease resistance, providing new ways and more choices for the breeding and application of tobacco brown spot disease-resistant varieties.

[0005] In order to solve the above technical problems, the present invention provides a NtAP1L protein resistant to tobacco brown spot disease. The amino acid sequence of the NtAP1L protein is shown in SEQ ID NO.2.

[0006] In order to solve the above technical problems, the present invention also provides a gene encoding NtAP1L protein, and the nucleotide sequence of the gene is shown in SEQ ID NO.1.

[0007] In order to solve the above technical problems, the present invention also provides the use of NtAP1L protein in preparing a product for identifying or breeding germplasm resources resistant to tobacco brown spot disease.

[0008] In order to solve the above technical problems, the present invention also provides the use of genes in preparing products for identifying or breeding germplasm resources resistant to tobacco brown spot disease.

[0009] Compared with the prior art, the beneficial effects of the present invention are: the present invention develops new genes and related proteins with tobacco brown spot disease resistance, providing new ways and more choices for the breeding and application of tobacco brown spot disease-resistant varieties. BRIEF DESCRIPTION OF THE DRAWINGS

[0010] Figure 1 The results of disease resistance analysis of homozygous strains with different base types at the differential site InDel 25 in the population GATS08 of the present invention (n≥20);

[0011] Figure 2 The position of the site InDel 25 and the structure of the gene Nitab4.5_0005495g0010 of the embodiment of the present invention;

[0012] Figure 3 The expression results of NtAP1L in various varieties of the embodiments of the present invention are shown in FIG.

[0013] Figure 4 This is a subcellular localization map of the tobacco NtAP1L protein according to an embodiment of the present invention. DETAILED DESCRIPTION

[0014] In order to make the objectives, technical solutions and advantages of the present invention more clearly understood, the present invention is further described in detail below in conjunction with embodiments and drawings. The exemplary embodiments of the present invention and their description are only used to explain the present invention and are not intended to limit the present invention.

[0015] Example:

[0016] In this embodiment, a hybrid combination was constructed using the brown spot disease susceptible variety G140 as the female parent and the brown spot disease resistant variety Oxford 26 as the male parent to obtain an F2 generation segregation population (GATS07); a hybrid combination was constructed using the brown spot disease susceptible variety G140 as the female parent and the brown spot disease resistant variety Jingyehuang as the male parent to obtain an F2 generation segregation population (GATS08). The experiment in this embodiment was conducted in the form of natural disease occurrence in the field and identification of resistance. The experiment was carried out using large-area planting without replication, and no chemical agent for preventing and controlling tobacco brown spot disease was applied during the experiment.

[0017] The resistance of offspring lines of two F2 generation segregation populations to brown spot disease was identified. 20 resistant lines and 20 susceptible lines were selected, and plant DNA was extracted using the CTAB method. The DNA of the resistant lines and susceptible lines was mixed in equal amounts, and the genome was sequenced using the sequencing platform IlluminaHiSeq 2000. The obtained raw sequencing data was quality controlled and then compared with the reference genome. SNPs and other tests and annotations were performed based on the comparison results to locate the functional annotations of candidate genes for differential traits.

[0018] First, specific primers were designed using the 500bp sequence upstream and downstream of the target site as a template. The tobacco genomic DNA was extracted using the plant genomic DNA extraction kit of Tiangen Company, and the target fragment was amplified using it as a template. The PCR product was sent to a biological company for sequencing, and the target fragment was compared with the reference genome using DNAMAN. According to the restriction sites contained in the NtBS5 and NtAP1L gene sequences and the pBWA(V)HS vector sequence, PCR primers with restriction sites at the 5' end were designed, and the plasmid was transformed into the competent E. coli, and positive clones were screened using PCR technology.

[0019] As shown in Table 1, in this example, a total of 29 differential sites were screened by sequencing the simplified genome pool of disease-resistant strains and susceptible strains of two F2 populations. In addition, a total of 7 differential sites were in the exon region, and the remaining differential sites were all in the promoter region 1500 bp upstream of the gene.

[0020] Table 1 Differential site information within 1500 bp upstream of exons and genes

[0021]

[0022]

[0023] In order to study the relationship between the differential loci obtained in the GATS08 population and resistance to brown spot disease, specific primers were designed using the 500bp sequence upstream and downstream of the differential loci as templates to amplify the distribution of the differential loci between the F2 generation disease-resistant pool plants and the susceptible pool plants. See Table 2. The results show that homozygous genotype strains consistent with the disease-resistant parent Jingyehuang and the susceptible parent G140 were detected in both the disease-resistant pool plants and the susceptible pool plants. A total of 11 InDel 25 genotype homozygous strains were detected, including 5 genotypes of the disease-resistant parent Jingyehuang, all of which showed disease resistance; and 6 genotypes of the susceptible parent G140, all of which showed disease sensitivity. In addition, the genotype homozygous strains of the remaining differential loci were also detected in the disease-resistant pool plants and the susceptible pool plants, but their disease resistance phenotypes were not completely consistent with this genotype. From the above results, it can be seen that the differential locus InDel 25 may also be closely related to tobacco brown spot disease resistance, which requires further in-depth research.

[0024] Table 2 Linkage segregation analysis of brown spot resistance at each SNP locus in resistant and susceptible lines in population GATS08

[0025]

[0026]

[0027] By verifying the sequence of the differential locus InDel 25 in some known brown spot disease resistant germplasm resources, the correlation between the obtained differential loci and brown spot disease resistance was preliminarily studied. See Table 3. The results show that all the germplasm resources tested that are susceptible to brown spot disease have no base deletions. On the contrary, all germplasm resources with base deletions in InDel 25 show resistance to brown spot disease. Therefore, it can be further inferred that InDel 25 is closely related to brown spot disease resistance.

[0028] Table 3 Sequence analysis of InDel 25 loci in some germplasm resources

[0029]

[0030] From the above results, it can be seen that the differential locus InDel 25, which is closely related to the resistance to brown spot disease, has mutated in all the known brown spot disease-resistant germplasm resources with pure yellow leaves. Therefore, detecting the brown spot disease resistance of the homozygous variant strains of InDel 25 base and the homozygous non-mutated strains in the offspring population will help to further determine the relationship between the above differential loci and the resistance to brown spot disease of tobacco. Figure 1 The results showed that at two different survey points, the brown spot disease grade of the strain with no base deletion at the InDel 25 site (GA) was significantly higher than that of the strain with base deletion (--), further indicating that the InDel 25 site is closely related to brown spot disease resistance.

[0031] See attached Figure 2 , site InDel 25 is located at 697bp in the upstream region of gene Nitab4.5_0005495g0010, and the reference genome base sequence is GA. The sequence length of gene Nitab4.5_0005495g0010 is 3714bp, with three coding regions totaling 775bp. The GO annotation is acid phosphatase 1-like, and it is named NtAP1L. The sequencing results show that the full length of the NtAP1L genome is 3714bp, with 3 exon regions totaling 774bp and 2 intron regions. The NtAP1L coding region encodes a total of 257 amino acids, with an isoelectric point of 4.61 and a molecular weight of 29.32KD. The nucleotide sequence of the NtAP1L gene and its encoded amino acid sequence are as follows:

[0032]

[0033]

[0034] By studying the expression of NtAP1L in red star disease-susceptible varieties with no base deletion and red star disease-resistant varieties with base deletion before and after infection with the red star disease fungus Alternaria alternata, it was shown that before infection with Alternaria alternata, the expression of NtAP1L in each variety was quite different. Figure 3 The expression level was extremely low in red spot disease-susceptible varieties with no base deletions, such as G140, NC82, Yunyan 87 and K326, but increased by 40-80 times in red spot disease-resistant varieties with base deletions, such as Oxford 26, Jingyehuang, YA-2, Zijiang No. 1, Zhongyan 100 and Dabaijin 599. After infection with Alternaria alternata, the expression level of NtAP1L was greatly increased in the red spot disease-susceptible varieties G140, Yunyan 87, NC82 and K326, while the expression level of NtAP1L in the red spot disease-resistant varieties Oxford 26, Jingyehuang, YA-2, Zijiang No. 1, Zhongyan 100, Dabaijin 599 was further increased by 200-400 times, indicating that the base deletion in the upstream region has an important effect on the expression of the NtAP1L gene, and the NtAP1L gene is involved in the defense response of tobacco plants against infection with red spot disease.

[0035] See attached Figure 4 In this example, green fluorescent protein was linked to NtAP1L to study the subcellular localization of NtAP1L protein. The results showed that NtAP1L was localized in the cell nucleus, and it was speculated that it was a secretory protein that was ultimately transported to the cell nucleus.

[0036] The above is an embodiment of the present invention. The above embodiments and the specific parameters in the embodiments are only for the purpose of clearly describing the invention verification process, and are not intended to limit the patent protection scope of the present invention. The patent protection scope of the present invention is still subject to its claims. Any equivalent structural changes made by using the contents of the description and drawings of the present invention should be included in the protection scope of the present invention. Sequence Listing <110> Guizhou Tobacco Science Research Institute <120> A NtAP1L protein resistant to tobacco brown spot disease and its encoding gene and application <140> 202111120072.6 <141> 2021-09-24 <160> 2 <170> SIPOSequenceListing 1.0 <210> 1 <211> 774 <212> DNA <213> Artificial Sequence <400> 1 atgagaattt tcagtttctt gattctgttt agtttcgcct ttggacatga aaatcttaat 60 accttaattg ttgagttccc tgaaaatact gaaccccaat tgaaggaaac cattattgat 120 gttgaattag agtgtacaag ttggaggttt gctgtggagg ctaataattt aagcccatgg 180 aagactattc caaaggaatg tgctgattac gtgaggcaat atattaatgg cggggcttat 240 aagttggaca ttgatagagt ttcaagtgaa gctggagcct atgcagaaag catgaaattg 300 ggcgcagatg gaaaagatgt atggattttt gatgttgatg agactttgct ttcaaatctt 360 ccctattatt cgcaacatgg ctatgggttg gaggtatttg atagtgtgaa attcgatgaa 420 tgggttgaga agggagtggc accagccatt gggtcaagtt tgaagcttta tcaagatgtt 480 atgaggctag gattcaaagt gttcttgctt actgggcgta gtgaaagaca cagaattgtt 540 acagtggaga atttgatgaa tgctggtttt caggattggg acaagctgat actgaggggc 600 tcggaggatc atggaaaatc agccacaatt tataaatcag agaaaaggga tgagatggtt 660 gaagaggggt ttagaatagt aggcaactct ggagaccagt ggagtgatct gttgggttcc 720 tctacttcta ttcgctcgtt caagcttcct aacccaatgt actacattcc ttga 774 <210> 2 <211> 257 <212> PRT <213> Artificial Sequence <400> 2 Met Arg Ile Phe Ser Phe Leu Ile Leu Phe Ser Phe Ala Phe Gly His 1 5 10 15 Glu Asn Leu Asn Thr Leu Ile Val Glu Phe Pro Glu Asn Thr Glu Pro 20 25 30 Gln Leu Lys Glu Thr Ile Ile Asp Val Glu Leu Glu Cys Thr Ser Trp 35 40 45 Arg Phe Ala Val Glu Ala Asn Asn Leu Ser Pro Trp Lys Thr Ile Pro 50 55 60 Lys Glu Cys Ala Asp Tyr Val Arg Gln Tyr Ile Asn Gly Gly Ala Tyr 65 70 75 80 Lys Leu Asp Ile Asp Arg Val Ser Ser Glu Ala Gly Ala Tyr Ala Glu 85 90 95 Ser Met Lys Leu Gly Ala Asp Gly Lys Asp Val Trp Ile Phe Asp Val 100 105 110 Asp Glu Thr Leu Leu Ser Asn Leu Pro Tyr Tyr Ser Gln His Gly Tyr 115 120 125 Gly Leu Glu Val Phe Asp Ser Val Lys Phe Asp Glu Trp Val Glu Lys 130 135 140 Gly Val Ala Pro Ala Ile Gly Ser Ser Leu Lys Leu Tyr Gln Asp Val 145 150 155 160 Met Arg Leu Gly Phe Lys Val Phe Leu Leu Thr Gly Arg Ser Glu Arg 165 170 175 His Arg Ile Val Thr Val Glu Asn Leu Met Asn Ala Gly Phe Gln Asp 180 185 190 Trp Asp Lys Leu Ile Leu Arg Gly Ser Glu Asp His Gly Lys Ser Ala 195 200 205 Thr Ile Tyr Lys Ser Glu Lys Arg Asp Glu Met Val Glu Glu Gly Phe 210 215 220 Arg Ile Val Gly Asn Ser Gly Asp Gln Trp Ser Asp Leu Leu Gly Ser 225 230 235 240 Ser Thr Ser Ile Arg Ser Phe Lys Leu Pro Asn Pro Met Tyr Tyr Ile 245 250 255 Pro

Claims

1. Use of a NtAP1L protein resistant to tobacco brown spot disease in preparing a product for identifying or breeding tobacco brown spot disease resistant germplasm resources, wherein the amino acid sequence of the NtAP1L protein is shown in SEQ ID NO.2, and the nucleotide sequence of the gene of the NtAP1L protein is shown in SEQ ID NO.

1.

2. Use of the gene of the NtAP1L protein according to claim 1 in preparing a product for identifying or breeding germplasm resources resistant to tobacco brown spot disease.